TWI635803B - 營養奶精組成物 - Google Patents
營養奶精組成物 Download PDFInfo
- Publication number
- TWI635803B TWI635803B TW102124518A TW102124518A TWI635803B TW I635803 B TWI635803 B TW I635803B TW 102124518 A TW102124518 A TW 102124518A TW 102124518 A TW102124518 A TW 102124518A TW I635803 B TWI635803 B TW I635803B
- Authority
- TW
- Taiwan
- Prior art keywords
- grams
- oil
- weight
- acid
- nutrition product
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 218
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 152
- 230000035764 nutrition Effects 0.000 claims abstract description 47
- 235000019197 fats Nutrition 0.000 claims abstract description 31
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 22
- 239000008158 vegetable oil Substances 0.000 claims abstract description 22
- 235000021003 saturated fats Nutrition 0.000 claims abstract description 8
- 235000021084 monounsaturated fats Nutrition 0.000 claims abstract description 4
- 235000021085 polyunsaturated fats Nutrition 0.000 claims abstract description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 48
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 40
- 235000018102 proteins Nutrition 0.000 claims description 32
- 102000004169 proteins and genes Human genes 0.000 claims description 32
- 108090000623 proteins and genes Proteins 0.000 claims description 32
- 239000003921 oil Substances 0.000 claims description 31
- 235000019198 oils Nutrition 0.000 claims description 31
- 235000013365 dairy product Nutrition 0.000 claims description 27
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 24
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 24
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 24
- 239000005642 Oleic acid Substances 0.000 claims description 24
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 24
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 24
- 235000021313 oleic acid Nutrition 0.000 claims description 24
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 21
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 20
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 20
- 150000001720 carbohydrates Chemical class 0.000 claims description 19
- 235000014633 carbohydrates Nutrition 0.000 claims description 19
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 15
- 235000019486 Sunflower oil Nutrition 0.000 claims description 14
- 150000002632 lipids Chemical class 0.000 claims description 14
- 239000002600 sunflower oil Substances 0.000 claims description 14
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 claims description 13
- 102000007544 Whey Proteins Human genes 0.000 claims description 12
- 108010046377 Whey Proteins Proteins 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 12
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 claims description 11
- 239000008164 mustard oil Substances 0.000 claims description 11
- 108010076119 Caseins Proteins 0.000 claims description 10
- 102000011632 Caseins Human genes 0.000 claims description 10
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 10
- 229960004488 linolenic acid Drugs 0.000 claims description 10
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 10
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 9
- 235000012424 soybean oil Nutrition 0.000 claims description 9
- 239000003549 soybean oil Substances 0.000 claims description 9
- 235000021119 whey protein Nutrition 0.000 claims description 9
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 102000014171 Milk Proteins Human genes 0.000 claims description 6
- 108010011756 Milk Proteins Proteins 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 6
- 235000021239 milk protein Nutrition 0.000 claims description 6
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- 235000019485 Safflower oil Nutrition 0.000 claims description 5
- 235000005687 corn oil Nutrition 0.000 claims description 5
- 239000002285 corn oil Substances 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 235000010445 lecithin Nutrition 0.000 claims description 5
- 239000000787 lecithin Substances 0.000 claims description 5
- 229940067606 lecithin Drugs 0.000 claims description 5
- 239000011591 potassium Substances 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- 235000007686 potassium Nutrition 0.000 claims description 5
- 235000005713 safflower oil Nutrition 0.000 claims description 5
- 239000003813 safflower oil Substances 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 4
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- 229940080237 sodium caseinate Drugs 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- 229930003799 tocopherol Natural products 0.000 claims description 4
- 239000011732 tocopherol Substances 0.000 claims description 4
- 235000019149 tocopherols Nutrition 0.000 claims description 4
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 claims description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 3
- 239000006057 Non-nutritive feed additive Substances 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 235000021314 Palmitic acid Nutrition 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 235000020209 toddler milk formula Nutrition 0.000 claims description 3
- 229920000881 Modified starch Polymers 0.000 claims description 2
- 239000004368 Modified starch Substances 0.000 claims description 2
- 239000000944 linseed oil Substances 0.000 claims description 2
- 235000019426 modified starch Nutrition 0.000 claims description 2
- 235000013350 formula milk Nutrition 0.000 abstract description 23
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 16
- 229930195729 fatty acid Natural products 0.000 abstract description 16
- 239000000194 fatty acid Substances 0.000 abstract description 16
- 150000004665 fatty acids Chemical class 0.000 abstract description 16
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 28
- 239000000047 product Substances 0.000 description 27
- 229920002498 Beta-glucan Polymers 0.000 description 21
- 229910052500 inorganic mineral Inorganic materials 0.000 description 20
- 235000010755 mineral Nutrition 0.000 description 20
- 239000011707 mineral Substances 0.000 description 20
- 239000006041 probiotic Substances 0.000 description 19
- 235000018291 probiotics Nutrition 0.000 description 19
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 18
- 229940088594 vitamin Drugs 0.000 description 17
- 229930003231 vitamin Natural products 0.000 description 17
- 235000013343 vitamin Nutrition 0.000 description 17
- 239000011782 vitamin Substances 0.000 description 17
- 235000021342 arachidonic acid Nutrition 0.000 description 14
- 229940114079 arachidonic acid Drugs 0.000 description 14
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 12
- 229940077731 carbohydrate nutrients Drugs 0.000 description 11
- 235000013336 milk Nutrition 0.000 description 11
- 239000008267 milk Substances 0.000 description 11
- 210000004080 milk Anatomy 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 10
- 229960001031 glucose Drugs 0.000 description 10
- 235000015097 nutrients Nutrition 0.000 description 10
- 229920001542 oligosaccharide Polymers 0.000 description 10
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 9
- 229960001231 choline Drugs 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 229910052742 iron Inorganic materials 0.000 description 9
- 229960003284 iron Drugs 0.000 description 9
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 8
- -1 ascorbyl palmitate) Chemical class 0.000 description 8
- 235000005911 diet Nutrition 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000013355 food flavoring agent Nutrition 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 229920001503 Glucan Polymers 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 7
- 239000003797 essential amino acid Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 239000005018 casein Substances 0.000 description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 6
- 235000021240 caseins Nutrition 0.000 description 6
- 239000000306 component Substances 0.000 description 6
- 230000000378 dietary effect Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 235000008504 concentrate Nutrition 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 235000001968 nicotinic acid Nutrition 0.000 description 5
- 239000011664 nicotinic acid Substances 0.000 description 5
- 235000006180 nutrition needs Nutrition 0.000 description 5
- 230000000529 probiotic effect Effects 0.000 description 5
- 229920001100 Polydextrose Polymers 0.000 description 4
- 244000299461 Theobroma cacao Species 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 229930003270 Vitamin B Natural products 0.000 description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 235000020776 essential amino acid Nutrition 0.000 description 4
- 235000004626 essential fatty acids Nutrition 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 235000020256 human milk Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 235000013856 polydextrose Nutrition 0.000 description 4
- 239000001259 polydextrose Substances 0.000 description 4
- 229940035035 polydextrose Drugs 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 235000009499 Vanilla fragrans Nutrition 0.000 description 3
- 244000263375 Vanilla tahitensis Species 0.000 description 3
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- 239000005862 Whey Substances 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 229940087168 alpha tocopherol Drugs 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 235000019219 chocolate Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 3
- 150000003271 galactooligosaccharides Chemical class 0.000 description 3
- 230000007366 host health Effects 0.000 description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 3
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 3
- 229960000511 lactulose Drugs 0.000 description 3
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 3
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 3
- 235000021073 macronutrients Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229960002969 oleic acid Drugs 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 235000019192 riboflavin Nutrition 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000002151 riboflavin Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 229940091258 selenium supplement Drugs 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 235000004835 α-tocopherol Nutrition 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000014510 cooky Nutrition 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- 229960000355 copper sulfate Drugs 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000020979 dietary recommendations Nutrition 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000011773 ferrous fumarate Substances 0.000 description 2
- 235000002332 ferrous fumarate Nutrition 0.000 description 2
- 229960000225 ferrous fumarate Drugs 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 229940014144 folate Drugs 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 2
- 229960004232 linoleic acid Drugs 0.000 description 2
- 208000018773 low birth weight Diseases 0.000 description 2
- 231100000533 low birth weight Toxicity 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 235000021400 peanut butter Nutrition 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 2
- 239000011678 thiamine pyrophosphate Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 235000021126 varied diet Nutrition 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 239000011652 vitamin K3 Substances 0.000 description 2
- 235000012711 vitamin K3 Nutrition 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 229940041603 vitamin k 3 Drugs 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- OAJLVMGLJZXSGX-CXGXMSGESA-L (2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4z,9z,14z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8 Chemical compound [Co+3].O[C@@H]1[C@H](O)[C@@H]([CH2-])O[C@H]1N1C2=NC=NC(N)=C2N=C1.O([C@H]1[C@H]([C@H](O[C@@H]1CO)N1C2=CC(C)=C(C)C=C2N=C1)O)P([O-])(=O)OC(C)CNC(=O)CCC1(C)C(CC(N)=O)C2[N-]\C1=C(C)/C(C(C\1(C)C)CCC(N)=O)=N/C/1=C\C(C(C/1(CC(N)=O)C)CCC(N)=O)=N\C\1=C(C)/C1=NC2(C)C(C)(CC(N)=O)C1CCC(N)=O OAJLVMGLJZXSGX-CXGXMSGESA-L 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- GMRQFYUYWCNGIN-ZVUFCXRFSA-N 1,25-dihydroxy vitamin D3 Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-ZVUFCXRFSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 240000004731 Acer pseudoplatanus Species 0.000 description 1
- 235000002754 Acer pseudoplatanus Nutrition 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241001134770 Bifidobacterium animalis Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- YSAVZVORKRDODB-UHFFFAOYSA-N Diethyl tartrate Chemical compound CCOC(=O)C(O)C(O)C(=O)OCC YSAVZVORKRDODB-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000917009 Lactobacillus rhamnosus GG Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000006485 Platanus occidentalis Nutrition 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- XUORJVJJLCWVEG-UHFFFAOYSA-N [Ca].[Na].[Na].C(C)(=O)ON(CCN(OC(C)=O)OC(C)=O)OC(C)=O.[Ca] Chemical compound [Ca].[Na].[Na].C(C)(=O)ON(CCN(OC(C)=O)OC(C)=O)OC(C)=O.[Ca] XUORJVJJLCWVEG-UHFFFAOYSA-N 0.000 description 1
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000016127 added sugars Nutrition 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940002010 banana extract Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 229960002246 beta-d-glucopyranose Drugs 0.000 description 1
- 229940118852 bifidobacterium animalis Drugs 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 239000012075 bio-oil Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 229960001714 calcium phosphate Drugs 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- XDVNRYBLLJRCFU-BTVCFUMJSA-N calcium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound [Ca].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDVNRYBLLJRCFU-BTVCFUMJSA-N 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000010627 cedar oil Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229940046374 chromium picolinate Drugs 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 235000006279 cobamamide Nutrition 0.000 description 1
- 239000011789 cobamamide Substances 0.000 description 1
- ZIHHMGTYZOSFRC-UWWAPWIJSA-M cobamamide Chemical compound C1(/[C@](C)(CCC(=O)NC[C@H](C)OP(O)(=O)OC2[C@H]([C@H](O[C@@H]2CO)N2C3=CC(C)=C(C)C=C3N=C2)O)[C@@H](CC(N)=O)[C@]2(N1[Co+]C[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C3=NC=NC(N)=C3N=C1)O)[H])=C(C)\C([C@H](C/1(C)C)CCC(N)=O)=N\C\1=C/C([C@H]([C@@]\1(CC(N)=O)C)CCC(N)=O)=N/C/1=C(C)\C1=N[C@]2(C)[C@@](C)(CC(N)=O)[C@@H]1CCC(N)=O ZIHHMGTYZOSFRC-UWWAPWIJSA-M 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000021310 complex sugar Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940108928 copper Drugs 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 210000003520 dendritic spine Anatomy 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229960000878 docusate sodium Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
- 229940064302 folacin Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000020189 fortified milk Nutrition 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229940098330 gamma linoleic acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- DQOCFCZRZOAIBN-WZHZPDAFSA-L hydroxycobalamin Chemical compound O.[Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O DQOCFCZRZOAIBN-WZHZPDAFSA-L 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 244000000074 intestinal pathogen Species 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 229940059406 lactobacillus rhamnosus gg Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000003050 macronutrient Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- RAKQPZMEYJZGPI-LJWNYQGCSA-N menaquinone-7 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 RAKQPZMEYJZGPI-LJWNYQGCSA-N 0.000 description 1
- 235000009464 menaquinone-7 Nutrition 0.000 description 1
- 239000011700 menaquinone-7 Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000007672 methylcobalamin Nutrition 0.000 description 1
- 239000011585 methylcobalamin Substances 0.000 description 1
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- JOUIQRNQJGXQDC-ZYUZMQFOSA-L nicotinate D-ribonucleotide(2-) Chemical compound O1[C@H](COP([O-])([O-])=O)[C@@H](O)[C@@H](O)[C@@H]1[N+]1=CC=CC(C([O-])=O)=C1 JOUIQRNQJGXQDC-ZYUZMQFOSA-L 0.000 description 1
- 235000021253 non-digestible food component Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 150000002942 palmitic acid derivatives Chemical class 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 229940013712 pineapple extract Drugs 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- 229940093916 potassium phosphate Drugs 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960004860 thiamine mononitrate Drugs 0.000 description 1
- 235000019191 thiamine mononitrate Nutrition 0.000 description 1
- 239000011748 thiamine mononitrate Substances 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 229960002363 thiamine pyrophosphate Drugs 0.000 description 1
- AYEKOFBPNLCAJY-UHFFFAOYSA-O thiamine pyrophosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N AYEKOFBPNLCAJY-UHFFFAOYSA-O 0.000 description 1
- IWLROWZYZPNOFC-UHFFFAOYSA-O thiamine triphosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N IWLROWZYZPNOFC-UHFFFAOYSA-O 0.000 description 1
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000015149 toffees Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/003—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Pediatric Medicine (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Grain Derivatives (AREA)
Abstract
本發明提供包含植物油摻和物之營養奶精組成物,其中該植物油摻和物提供適當之脂肪酸組合形廓或飽和脂肪、多不飽和脂肪、單不飽和脂肪及反式脂肪酸。在此處所述之奶精組成物可用作各種營養組成物(諸如嬰兒配方、兒童營養產品及成人營養組成物)之脂肪來源。本發明亦提供包含上述之奶精組成物的營養組成物。
Description
本揭露內容大體上關於包含提供適當之脂肪酸組合形廓之植物油摻和物的營養奶精。此處所揭露之奶精組成物可用作營養組成物(諸如嬰兒配方、兒童營養產品及成人營養組成物)之脂肪來源。
營養組成物(諸如嬰兒配方、兒童營養產品及成人營養組成物)可提供嬰兒、兒童及成人部分或完整的營養。除其他營養素外,這類營養組成物通常包括具適量之脂肪的脂肪來源,更特別地,適量之飽和脂肪酸、單不飽和脂肪酸、多不飽和脂肪酸及反式脂肪酸。更特別地,某些脂肪酸(諸如油酸、亞油酸及α-亞麻仁油酸)已被公認可支持人類之成長、發育和終身健康。因此,提供用於營養組成物之合適的脂肪來源,同時保持該營養組成物之感官特徵是有需要的。合適的脂肪來源亦應為貨架穩定且很容易被納入營養組成物中。
本揭露內容提供可用作各種營養組成物(尤其是嬰兒配方、兒童營養產品及成人營養組成物)之脂肪來源的營養奶精組成物。該奶精組成物包含一定量之飽和脂肪酸、多不飽和脂肪酸、單不飽和脂肪酸及反式脂肪酸。更特別地,該奶精組成物提供一定量之脂肪酸,包括油酸、亞油酸、α-亞麻仁油酸。於一些實施例中,該摻和物包含至多約15重量%之飽和脂肪酸(例如約3至約15重量%之飽和脂肪酸);約45至約75重量%之單不飽和脂肪酸;約15至約45重量%之多不飽和脂肪酸;及至多約3重量%之反式脂肪酸,例如約0.1至約3重量%。於進一步之實施例中,該奶精摻和物包含約45至約75重量%之油酸、約10至約40重量%之亞油酸、及約1至約15重量%之α-亞麻仁油酸。
該奶精組成物包含提供上述脂肪酸組合形廓之植物油摻和物。例如,於某些實施例中,該奶精組成物包含芥菜油、大豆油或葵花油及高油酸油(high oleic oil)之植物油摻和物。於一些實施例中,該奶精組成物包含植物油摻和物,該植物油摻和物包含約30至約70重量%之芥菜油、約10至約45重量%之大豆油及約10至約50重量%之高油酸油,而於其他實施例中,該奶精組成物包含植物油摻和物,該植物油摻和物包含約30至約70重量%之芥菜油、約10至約45重量%之葵花油及約10
至約50重量%之高油酸油。較佳地,該高油酸油係選自下列所組成之群組:高油酸葵花油、高油酸玉米油、高油酸大豆油、高油酸芥菜油、高油酸紅花油及彼等之混合物。
於一些實施例中,該奶精組成物係以粉末形式提供,諸如經噴霧乾燥之基質。該奶精組成物可選擇性地包含至少一種載體、穩定劑、乳化劑、抗氧化劑、加工助劑及彼等之混合物。例如,於一些實施例中,本組成物進一步包含玉米糖漿固體、酪蛋白酸鹽、單甘油酯、二甘油酯、棕櫚酸抗壞血酸酯、卵磷脂、混合之生育酚、麥芽糊精、乳糖、澱粉、乳清蛋白濃縮物、磷酸鹽、檸檬酸鹽及彼等之混合物。
此處所揭露之奶精組成物可用於在各種營養配方(包括嬰兒配方、兒童營養產品(諸如成長乳品)及成人營養產品)中提供脂肪來源。例如,根據本揭露內容之營養組成物包含蛋白質來源、碳水化合物來源及包含如此處所述之奶精組成物的脂肪來源。較佳地,該營養組成物包含至多約50重量%之奶精組成物。例如,於一些實施例中,該營養組成物包含約5至約50重量%之奶精組成物的。更佳地,該營養組成物包含約10至約40重量%之奶精組成物、約15至約30重量%之奶精組成物,甚至更佳地,約18%至約27重量%之奶精組成物、或約20%至約25重量%之奶精組成物。
於某些實施例中,上述之營養組成物包含每
100克之該營養組成物中約8至約19克之脂肪、約50至約65克之碳水化合物及約14至約25克之蛋白質。此外,於某些實施例中,該營養組成物包含每100克之該營養組成物中約1至約7克之飽和脂肪、約2.5至約10克之單不飽和脂肪、約0.5至約10克之多不飽和脂肪、及約0.1至1克之反式脂肪。於一些實施例中,該營養組成物包含每100克之該營養組成物中約0.5至約5克之棕櫚酸、約0.5至約2克之硬脂酸、約1至約10克之油酸、約0.5至約8克之亞油酸、約0.1至約2克之α-亞麻仁油酸、及約25至約200毫克之二十二碳六烯酸。
現在將更詳細地介紹本揭露內容之實施例,下文中提出其一或多個實例。提供之各實例係用於解釋本揭露內容之營養組成物,而非用於限制。事實上,熟習本技藝之人士將清楚明白本揭露內容之教示內容可在不背離本揭露內容之範圍或精神下做各種修改和變化。例如,所說明或描述之為一種實施例的一部分之特性可與另一實施例一起使用,以產生另一實施例。
因此,本揭露內容欲涵蓋在附屬之申請專利範圍及彼等之等同物之範圍內的這類修改和變化。本揭露內容之其他的目的、特性及觀點揭露在下列詳細描述中或可從其中顯明。本技藝之一般技術人士可理解本討論內容僅為示例性實施例之描述而不欲限制本揭露內容之更廣泛
的觀點。
“營養組成物”意指滿足至少一部分對象之營養需求的物質或配方。在本揭露內容之全文中,術語“營養”、“營養配方”、“腸內營養”、“營養組成物”及“營養補充劑”可以互換使用以指腸內配方、口服配方、嬰兒配方、兒科對象之配方、兒童配方、成長乳品和/或成人配方之液體、粉末、凝膠、糊劑、固體、濃縮液、懸浮液或即時可用的形式。
“嬰兒”係指年齡不超過約一歲之對象且包括0至12個月之嬰兒。術語嬰兒包括低出生體重嬰兒、極低出生體重之嬰兒和早產兒。“早產”意指在妊娠37週結束前出生的嬰兒。足月兒亦包括產前嬰兒,例如仍然在子宮內的嬰兒。
“兒童”或“兒科對象”意指年齡在12個月至約13歲之範圍內的人類對象。於一些實施例中,兒童為年齡在1歲至12歲之間的對象。於其他實施例中,術語“兒童們”或“兒童”係指約1至約6歲,或約7至約12歲之對象。於其他實施例中,術語“兒童們”或“兒童”係指介於約12個月至約13歲之間的任何年齡範圍。
“兒童營養產品”係指滿足至少一部分之兒童營養需求的組成物。成長乳品為兒童營養產品之一種實例。
“嬰兒配方”意指滿足至少一部分之嬰兒營養需求的組成物。在美國,嬰兒配方之內容係由21
C.F.R.章節100、106、及107中所載之聯邦法規規定。這些法規規定大量營養素、維生素、礦物質、及其他成分水準以努力模擬人類母乳之營養和其他性能。
術語“成長乳品”係指廣泛類別之欲用作多樣化膳食之一部分以支持年齡約1至6歲之兒童的正常生長和發育的營養組成物。
“以乳品為底質”意指包含至少一種已從哺乳動物之乳腺提出或萃取之組分。於一些實施例中,以乳品為底質之營養組成物包含源自家養有蹄類動物、反芻動物、或其他哺乳動物、或彼等之任何組合的乳品組分。此外,於一些實施例中,以乳品為底質意指包含牛酪蛋白、乳清、乳糖、或彼等之任何組合。此外,“以乳品為底質之營養組成物”可能指包含本技藝已知之任何源自乳品或以乳品為底質的產品之任何組成物。
“營養完整的”意指可用作唯一之營養來源的組成物,該組成物可實質上提供所有每日需要量之與蛋白質、碳水化合物和脂類組合的維生素、礦物質和/或微量元素。確實,“營養完整的”係描述能提供支持對象正常生長和發育所需之足量碳水化合物、脂質、必須脂肪酸、蛋白質、必須胺基酸、半必須胺基酸、維生素、礦物質和能源予對象的營養組成物。
因此,顧名思義,對早產兒“營養完整”的營養組成物將定性且定量地提供早產兒成長所需之足量之碳水化合物、脂質、必須脂肪酸、蛋白質、必須胺基酸、
半必須胺基酸、維生素、礦物質和能源。
顧名思義,對足月兒“營養完整”的營養組成物將定性且定量地提供足月兒成長所需之足量的全部碳水化合物、脂質、必須脂肪酸、蛋白質、必須胺基酸、半必須胺基酸、維生素、礦物質和能源。
顧名思義,對兒童“營養完整”的營養組成物將定性且定量地提供兒童成長所需之足量的全部碳水化合物、脂質、必須脂肪酸、蛋白質、必須胺基酸、半必須胺基酸、維生素、礦物質和能源。
當應用於營養素時,術語“必須”係指身體無法合成足夠量以用於正常生長及維持健康,因此必須由飲食供應的任何營養素。術語“半必須”當應用於營養素時意指當無法供應身體足夠量之先質化合物以進行內源性合成時,必須經由飲食提供之營養素。
“益生菌”意指能對宿主健康發揮有益影響之具有低或無致病性的微生物。
“益菌素”意指能經由選擇性地刺激消化道中一種或有限數量之腸道細菌之生長和/或活性、選擇性地減少腸道病原體、或有利地影響可改善宿主健康之腸道短鏈脂肪酸之組合形廓來有益地影響宿主之不易消化的食物成分。
“β-葡聚糖”或“乙型-葡聚糖”係指所有β-葡聚糖,包括β-1,3-葡聚糖及β-1,3;1,6-葡聚糖,因為其各為β-葡聚糖之特定類型。此外,β-1,3;1,6-葡聚糖為β-
1,3-葡聚糖之一種類型。因此,術語“β-1,3-葡聚糖”包括β-1,3;1,6-葡聚糖。
除非另有規定,此處所使用之百分比、份數及比例係以總配方之重量計。
本揭露內容之奶精組成物及營養組成物可能實質上不含此處所述之任何可選擇或選定之成分。在此背景下,除非另有規定,術語“實質上不含”意指該選定之組成物可能含有少於該可選擇成分之功能量,通常少於0.1重量%,且亦包括0重量%之這類可選擇或選定之成分。
本揭露內容之一種觀點係關於用於營養組成物(諸如嬰兒配方、兒童營養產品及成人營養配方)中之奶精組成物。更特別地,本揭露內容關於用於兒童營養產品(諸如成長乳品)之奶精組成物。該植物油摻和物具有有利的脂肪酸組合形廓能協助支持食用包含在此處所述之奶精組成物之營養組成物的個體之健康,同時,當用於營養組成物中時能維持良好的感官特性。於某些實施例中,該植物油摻和物包含至多約15重量%之飽和脂肪酸、約45至約75重量%之單不飽和脂肪酸、約15至約45重量%之多不飽和脂肪酸、及至多約3重量%之反式脂肪酸。於其他實施例中,該植物油摻和物包含至多約12重量%之飽和脂肪酸、約53至約67重量%之單不飽和脂肪酸、約23至約37重量%之多不飽和脂肪酸、及至多約1.5重量%之反式脂肪酸。
植物油摻和物提供合適量之某些脂肪酸,包括油酸、亞油酸及α-亞麻仁油酸。更特別地,於某些實施例中,該植物油摻和物包含約45至約70重量%之油酸、約10至約40重量%之亞油酸、及約2至約15重量%之α-亞麻仁油酸。於其他實施例中,該脂肪摻和物包含約50至約70重量%之油酸、約15%至約35%重量%之亞油酸、約3至約10重量%之α-亞麻仁油酸。再於其他實施例中,該植物油摻和物包含表1中所列之規格:
該奶精組成物包含提供適當之脂肪酸組合形廓的植物油摻和物。合適之油包括,但不限於芥菜油、大豆油、紅花油、棕櫚油、棕櫚仁油、玉米油、葵花油、椰子油、橄欖油及高油酸油。於某些實施例中,該植物油摻和物包含芥菜油、大豆油或葵花油、及高油酸油。更特別
地,於某些實施例中,該植物油摻和物包含約30至約70重量%之芥菜油、約10至約45重量%之大豆油及約10至約50重量%之高油酸油。於其他實施例中,該植物油摻和物包含約30至約70重量%之芥菜油、約10至約45重量%之葵花油及約10至約50重量%之高油酸油。於這些實施例中之任一實施例中,該高油酸油可選自下列所組成之群組:高油酸葵花油、高油酸玉米油、高油酸大豆油、高油酸芥菜油、高油酸紅花油及彼等之混合物。較佳地,該高油酸油包含高油酸葵花油。於某些實施例中,可用於本發明之組成物中的高油酸油包含至少約70%之油酸,或更佳地,至少約80%之油酸。
附加成分,諸如乳蛋白、改質澱粉、酪蛋白酸鉀或鈉、單或二甘油酯、棕櫚酸酯(例如棕櫚酸抗壞血酸酯)、卵磷脂、混合之生育酚、麥芽糊精、乳糖、澱粉、乳清蛋白濃縮物、磷酸鹽、檸檬酸鹽及彼等之混合物可能被包括在該奶精組成物中作為載體、穩定劑、乳化劑、抗氧化劑及加工助劑。於一些實施例中,該附加成分包括,但不限於玉米糖漿固體、酪蛋白酸鹽(鉀或鈉)、單甘油酯、二甘油酯、棕櫚酸抗壞血酸酯、卵磷脂及混合之生育酚。
該奶精組成物可為液體或糊狀,或有利的是,可為用於納入營養組成物中之粉末形式。於一些實施例中,該奶精組成物係以經噴霧乾燥之基質形式提供。因此,該粉末狀奶精組成物可有利地與其他成分乾式摻和以
包含在營養組成物中。較佳地,該粉末狀奶精組成物之貨架期至少為6個月,更佳地,至少9個月。於某些實施例中,該奶精有99.5%之顆粒尺寸大於或等於美國篩尺寸(USSS)20號,且100%大於USSS 12號。
於某些實施例中,該奶精組成物包含至少約40重量%之脂肪,較佳為至少50重量%,且更佳為至少約55重量%。於某些實施例中,該奶精包含約40至約70重量%之脂肪,較佳為約50至約60重量%之脂肪,更佳為約55至約58重量%之脂肪。
此處所揭露之奶精組成物可用作營養配方(包括嬰兒配方、兒童營養產品(諸如成長乳品)及成人營養產品)中之脂肪來源。根據本揭露內容之示例性營養組成物包含蛋白質來源、碳水化合物源,及包含此處所揭露之奶精組成物的脂肪來源。較佳地,該營養包含至多約50重量%之奶精組成物,例如約5至約50重量%之奶精組成物。更佳地,該營養組成物包含約10至約40重量%之奶精組成物,約15至約30重量%之奶精組成物,甚至更較佳地,約18至約27重量%之奶精組成物,或約20至約25重量%之奶精組成物。一種示例性營養組成物包含每100克營養組成物中約14至約25克之蛋白質來源,約50至約65克之碳水化合物來源,約5至約25克之脂肪來源。
於某些實施例中,本揭露內容之營養組成物包含下列大量營養素組合形廓:每100克之營養組成物中
約1至約7克之飽和脂肪、約2.5至約10克之單不飽和脂肪、約0.5至約10克之多不飽和脂肪及約0.1至1克之反式脂肪。此外,於某些實施例中,該營養組成物可包含每100克之營養組成物中約0.5至約5克之棕櫚酸、約0.5至約2克之硬脂酸、約1至約10克之油酸、約0.5至約8克之亞油酸、約0.1至約2克之α-亞麻仁油酸、及約25至約200毫克之二十二碳六烯酸。
於某些實施例中,該包含在此處所述之奶精的營養組成物之脂肪酸組合形廓包含每100克中約12至約19克之總脂肪、每100克中約2至約5克之飽和脂肪、每100克中約1至約5克之亞油酸、每100克中約0.5至約1克之α-亞麻仁油酸、每100克中約2至約5克之多不飽和脂肪酸、每100克中約0.2至約0.5克之反式脂肪酸。於特殊之實施例中,該營養組成物具有下列脂肪酸組合形廓:每100克中約15至約17克之總脂肪、每100克中約3.7至約3.8克之飽和脂肪、每100克中約2.7至約3.3克之亞油酸、每100克約0.7至約0.8克之α-亞麻仁油酸、每100克中約3.5至約4.3克之多不飽和脂肪酸、及每100克中約0.3至約0.4克之反式脂肪酸。
本揭露內容之營養組成物的脂肪酸組合形廓可進一步從該組成物之總能量百分比的角度表示。例如,於一些實施例中,包含本揭露內容之奶精組成物的營養組成物包含下列為總能量百分比形式之脂肪酸組合形廓:約20至約40%之總脂肪、10%或更少之飽和脂肪酸、10%
或更少之多不飽和脂肪酸、約4至約8%之亞油酸、約1至約2%之α-亞麻仁油酸、及1%或更少之反式脂肪酸。於特殊之實施例中,兒童營養產品(諸如用於1至3歲兒童之成長乳品)所包含之總能量中約30至約40%係來自脂肪,而欲用於4至6歲兒童之營養產品所包含之總能量中約20至約35%係來自脂肪。本揭露內容之營養組成物之改善的脂肪酸組合形廓與市售之成長乳品的比較提供於表2中。
所揭露之營養組成物可以本技藝中已知之任何形式提供,諸如粉末、凝膠、懸浮液、糊劑、固體、液體、液體濃縮液、可重構成之粉狀乳品替代品、或即時可用的產品。於某些實施例中,該營養組成物可包含營養補充品、兒童營養產品、嬰兒配方、人類母乳強化劑、成長乳品或任何其他為兒童對象設計之營養組成物。本揭露內
容之營養組成物包括,例如口服攝入之健康促進物質,包括,例如食品、飲料、片劑、膠囊及粉末。此外,本揭露內容之營養組成物可被標準化成特定之卡路里內容,其可以即時可用之產品的形式提供,或者它可以濃縮之形式提供。於一些實施例中,該營養組成物為粉末形式,其顆粒尺寸在5微米至1500微米之範圍內,更佳地,在10微米至1000微米之範圍內,甚至更佳地,在50微米至300微米之範圍內。
於一些實施例中,本揭露內容提供兒童營養產品,更特別地,為1-3歲和/或4-6歲之兒童設計的成長乳品,其中該成長乳品支持生長和發育、及終生健康。於一些實施例中,本揭露內容提供適合用於0至12個月、或0到3歲、0至6個月或6至12個月之嬰兒的配方。
除了本文他處所述之奶精組成物外,亦也可包含合適之脂肪或脂質來源。這類來源包括,但不限於動物來源,例如乳品脂肪、奶油、奶油脂肪,蛋黃脂質;海洋來源,諸如魚油、海洋生物油、單細胞油;蔬菜和植物油,諸如玉米油、芥花油、葵花油、大豆油、棕櫚油、椰子油、高油酸葵花油、月見草油、菜籽油、橄欖油、亞麻仁(亞麻籽)油、棉籽油、高油酸紅花油、棕櫚油硬脂、棕櫚仁油、小麥胚芽油;中鏈三酸甘油酯油和脂肪酸之乳劑和酯;以及彼等之任何組合。
碳水化合物來源可為本技藝中所使用之任何碳水化合物來源,例如乳糖、葡萄糖、果糖、玉米糖漿固
體、麥芽糊精、蔗糖、澱粉、稻米糖漿固體,等。營養組成物中之碳水化合物的量通常可在約5克至約25克/100千卡之間不變化。
本揭露內容之營養組成物亦可包含蛋白質來源。該蛋白質來源可為本技藝中所使用之任何蛋白質來源,例如脫脂乳、乳清蛋白、酪蛋白、大豆蛋白、水解蛋白、胺基酸,等。用於實行本揭露內容之牛乳蛋白來源包括,但不限於乳蛋白粉、乳蛋白濃縮物、乳蛋白分離物、脫脂乳固體、脫脂奶、脫脂乾乳、乳清蛋白、乳清蛋白分離物、乳清蛋白濃縮物、甜乳清、酸乳清、酪蛋白、酸酪蛋白、酪蛋白酸鹽(例如酪蛋白酸鈉、酪蛋白酸鈣鈉、酪蛋白酸鈣)及彼等之任何組合。
於一實施例中,該營養組成物之蛋白質係以完整蛋白質之形式提供。於其他實施例中,該蛋白質係以完整蛋白質與部分水解之蛋白質的組合物形式提供。於某些其他實施例中,該蛋白質被更完全水解。再於其他實施例中,該蛋白質來源包含胺基酸。再於其他實施例中,該蛋白質來源可輔以含麩醯胺之肽類。
於該營養組成物之一特定實施例中,該蛋白質來源之乳清蛋白:酪蛋白比例類似於在人類母乳中所發現者。於一實施例中,該蛋白質來源包含約40%至約80%之乳清蛋白和約20%至約60%之酪蛋白。該蛋白質的量通常可在每100千卡約1克至約7克蛋白質來源之間變化。
於一實施例中,該營養組成物可含有一或多種益生菌。本實施例可接受本技藝中之任何已知的益生菌。於特定之實施例中,該益生菌可選自以下群組中之任何益生菌:乳酸桿菌種(Lactobaeillus species),鼠李糖乳桿菌GG(Lactobacillus rhamnosus GG)(ATCC編號53103)、雙岐桿菌種(Bifidobacterium species)、長雙岐桿菌(Bifidobacterium longum)及動物雙歧桿菌乳亞種BB-12(Bifidobacterium animalis subsp.lactis BB-12)(DSM編號10140)或彼等之任何組合。
若包含在組成物中,該益生菌之量可在約1×104至約1×1010菌落形成單位(cfu)/公斤體重/天之間變化。於另一實施例中,該益生菌之量可在約1×106至約1×1010cfu/公斤體重/天之間變化。再於另一實施例中,該益生菌之量可在約1×107至約1×109cfu/公斤體重/天之間變化。再於另一實施例中,該益生菌之量可為至少約106cfu/公斤體重/天。
於一實施例中,該益生菌可為可存活菌或無法存活菌。如此處所使用之術語“可存活的”係指活的微生物。術語“無法存活的”或“無法存活的益生菌”係指無法存活之益生菌微生物、彼等之細胞組分和/或彼等之代謝物。這類無法存活的益生菌可能已經熱滅殺或經滅活,但其保留能有利地影響宿主健康的能力。可用於本揭露內容中之益生菌可為天然產生的、合成的或透過有機體之遺傳工程操作研發,無論這類新來源為現在已知的或稍
後研發的。
於某些實施例中,該營養組成物亦可含有一或多種益菌素。這類益菌素可為天然產生的、合成的或透過有機體和/或植物之遺傳工程操作研發,無論這類新來源為現在已知的或稍後研發的。可用於本揭露內容中之益菌素包括寡聚醣、多醣及其他含有果糖、木糖、大豆、半乳糖、葡萄糖和甘露糖之益菌素。
更具體地,可用於本揭露內容中之益菌素可包括聚右旋糖、聚右旋糖粉、乳果糖、乳果寡糖、棉籽糖、葡萄寡糖、菊糖、果寡糖(亦稱為寡果糖)、異麥芽寡糖、大豆寡糖、乳果糖、木寡糖、殼寡糖(chito-oligosaccharide)、甘露寡糖、阿拉伯寡糖(aribino-oligosaccharide)、唾液酸寡糖、岩藻寡糖(fuco-oligosaccharide)、半乳寡糖及龍膽寡糖(gentio-oligosaccharides)。
於一實施例中,存在於該營養組成物中之益菌素總量可為約1.0克/升至約10.0克/升組成物。該益菌素中至少20%可包含半乳寡糖、聚右旋糖或彼等之混合物。於一實施例中,在該營養組成物中之各半乳寡糖和/或聚右旋糖的量可在約1.0克/升至約4.0克/升的範圍內。
本揭露內容之營養組成物可含有包含二十二碳六烯酸之長鏈多不飽和脂肪酸(LCPUFA)來源。其他合適之LCPUFAs包括,但不限於α-亞油酸、γ-亞油酸、
亞油酸、亞麻仁油酸、二十碳五烯酸(EPA)及花生四烯酸(ARA)。
於一實施例中,尤其是若該營養組成物為嬰兒配方,該營養組成物係經補充DHA和ARA二者。於本實施例中,ARA:DHA之重量比可介於約1:3至約9:1之間。於一特定之實施例中,ARA:DHA之比為約1:2至約4:1之間。
該營養組成物可使用本技藝已知之標準技術輔來補充含有DHA和/或ARA之油。例如,DHA及ARA可經由取代通常存在於該組成物中之等量的油(諸如高油酸葵花油)而被添加在該組成物中。另一實例為該含有DHA和ARA之油可經由取代通常存在於該不含DHA和ARA之組成物中的全部脂肪摻合物之剩餘部分的等量而被添加到該組成物中。於某些實施例中,該配方包含DHA。
若包括DHA和/或ARA時,該DHA和/或ARA之來源可為本技藝已知之任何來源,諸如海洋油、魚油、單細胞油、蛋黃脂質及腦脂質。於一些實施例中,該DHA和ARA係源自單細胞Martek油、DHASCO®及ARASCO®、或彼等之變化。該DHA和ARA可為天然形式,其先決條件為該LCPUFA來源的其餘部分不會對該對象造成任何實質的有害影響。或者,可使用DHA和ARA之精製形式。
於一實施例中,該DHA和ARA之來源為如
美國專利案第5374657;5550156;和5397591號(其揭露內容全文以引用方式併入本文)中所揭示之單細胞油。然而,本揭露內容並不限於這類油。
該營養組成物亦可包含β-葡聚糖來源。葡聚糖為天然產生之多醣類(具體地說,葡萄糖之聚合物),且可在細菌、酵母菌、真菌和植物之細胞壁中找到。乙型葡聚糖(β-葡聚糖)本身為葡萄糖聚合物的不同子集,其係由經由β型糖苷鍵鏈接在一起以形成複合碳水化合物的葡萄糖單體鏈組成。
β-1,3-葡聚糖為天然產生之多醣,其帶有或不帶有在各種植物、酵母菌、真菌和細菌之細胞壁中發現的β-1,6-葡萄糖側鏈。(Stone BA,Clarke AE.Chemistry and Biology of(1-3)Beta-Glucans.London:Portland Press Ltd;1993。)β-1,3;1,6-葡聚糖為那些包含帶有(1,3)鏈接之葡萄糖單位者,其具有黏附在位置(1,6)處之側鏈。β-1,3;1,6-葡聚糖為一群分享結構共性(包括藉由β-1,3鍵鏈接之直鏈葡萄糖單位骨架,且具有從此骨架延伸之經β-1,6鏈接之葡萄糖分支)的異質性葡萄糖聚合物。雖然這是目前描述之β-葡聚糖類別的基本結構,一些變化可能是存在的。β-1,3-葡聚糖之化學結構取決於β-1,3-葡聚糖之來源。此外,各種理化參數(諸如溶解度、一級結構、分子量及分支)在β-1,3-葡聚糖之生物活性中發揮作用(Yadomae T.,Structure and biological activities of fungal beta- 1,3-glucans.Yakugaku Zasshi.2000;120:413-
431。)例如,某些酵母β-葡聚糖具有從β(1,6)分支延伸之其他β(1,3)分支區,這進一步增加其各別結構之複雜性。
衍生自麵包酵母,釀酒酵母(Saccharomyces cerevisiae)之β-葡聚糖係由連接在位置1和3之D-葡萄糖分子鏈所組成,其具有黏附在位置1和6處之葡萄糖側鏈。源自酵母之β-葡聚糖為不溶性、纖維狀之複合糖,其具有葡萄糖單位之一般直鏈結構,此直鏈結構具有β-1,3骨架,其間穿插一般長度為6-8個葡萄糖單位之β-1,6側鏈。更具體地說,源自麵包酵母之β-葡聚糖為聚(1,6)-β-D-吡喃葡萄糖基-(1,3)-β-D-吡喃葡萄糖。
此外,β-葡聚糖之耐受性良好且不會在兒科對象體內產生或引起過量氣體、腹脹(abdominal distension)、脹氣或腹瀉。在用於兒科對象之營養組成物(諸如嬰兒配方、成長乳品或其他兒童營養產品)中添加β-葡聚糖將經由增加對抗入侵病原體的抗性來改善兒科對象之免疫反應,從而保持或改善整體健康。
於一實施例中,本揭露內容之營養組成物包含膽鹼。膽鹼為正常細胞之功能所必要之營養素。其為膜磷脂之先質,且其加速乙醯膽鹼(此為涉及記憶儲存之神經遞質)的合成和釋出。此外,儘管不欲受此理論或任何其他理論約束,咸信,膳食膽鹼和二十二碳六烯酸(DHA)協同作用以促進生物合成磷脂醯膽鹼,從而協助促進人類對象中之突觸生成。此外,膽鹼和DHA可能顯
現出促進樹突棘形成之協同效果,這在維持已建立之突觸連接是很重要的。於一些實施例中,本揭露內容之營養組成物包含每8盎司用量約40毫克至約100毫克膽鹼。
於一實施例中,該營養組成物包含鐵之來源。於一實施例中,該鐵之來源為焦磷酸鐵、正磷酸鐵、富馬酸亞鐵或彼等之混合物,且於一些實施例中,可將該鐵之來源包封。
該營養組成物中亦可添加足以供應對象之每日營養需求的一或多種維生素和/或礦物質。本技藝之一般技術人士應理解維生素和礦物質需求會根據,例如兒童的年齡而有所不同。例如,嬰兒之維生素和礦物質需求可能與介於1至13歲之間的兒童不同。因此,該實施例並不欲將該營養組成物限制在特定之年齡組,而是提供可接受之維生素和礦物質組分的範圍。
於提供兒童營養組成物之實施例中,該組成物可選擇性地包括,但不限於一或多種下列維生素或彼等之衍生物:維生素B1(硫胺素、焦磷酸硫胺素、TTP、三磷酸硫胺素、TPP、鹽酸硫胺素、單硝酸硫胺素)、維生素B2(核黃素(riboflavin)、黃素單核苷酸、FMN、黃素腺嘌呤二核苷酸、FAD、核黃素(lactoflavin)、卵黃素(ovoflavin))、維生素B3(菸鹼酸(niacin)、菸鹼酸(nicotinic acid)、菸醯胺(nicotinamide)、菸醯胺(niacinamide)、菸醯胺腺嘌呤二核苷酸、NAD、菸鹼酸單核苷酸、NicMN、吡啶-3-羧酸)、維生素B3先質色胺
酸、維生素B6(吡哆醇、吡哆醛、吡哆胺、鹽酸吡哆醇)、泛酸(泛酸鹽、泛醇)、葉酸鹽(葉酸、葉酸(folacin)、蝶醯麩胺酸(pteroylglutamic acid))、維生素B12(鈷胺素、甲鈷胺素、脫氧腺苷鈷胺素、氰鈷胺素、羥鈷胺素、腺苷鈷胺素)、生物素、維生素C(抗壞血酸)、維生素A(視黃醇、醋酸視黃酯、棕櫚酸視黃酯、具其他長鏈脂肪酸之視黃酯、視黃醛、視黃酸、視黃醇酯)、維生素D(骨化醇、膽骨化醇、維生素D3、1,25-二羥基維生素D)、維生素E(α-生育酚、醋酸α-生育酚、琥珀酸α-生育酚、菸鹼酸α-生育酚、α-生育酚)、維生素K(維生素K1、葉綠醌、萘醌、維生素K2、甲萘醌(menaquinone)-7、維生素K3、甲萘醌-4、甲萘醌(menadione)、甲萘醌-8、甲萘醌-8H、甲萘醌-9、甲萘醌-9H、甲萘醌-10、甲萘醌-11、甲萘醌-12、甲萘醌-13)、膽鹼、肌醇、β-胡蘿葡素及彼等之任何組合。
於提供兒童之營養產品(諸如成長乳品)的實施例中,該組成物可選擇性地包括,但並不限於一或多種以下礦物質或彼等之衍生物:硼、鈣、醋酸鈣、葡萄糖酸鈣、氯化鈣、乳酸鈣、磷酸鈣、硫酸鈣、氯化物、鉻、氯化鉻、吡啶甲酸鉻、銅、硫酸銅(copper sulfate)、葡糖酸銅、硫酸銅(cupric sulfate)、氟化物、鐵、羰基鐵、三價鐵、富馬酸亞鐵、正磷酸鐵、研磨鐵、多醣鐵、碘化物、碘、鎂、碳酸鎂、氫氧化鎂、氧化鎂、硬脂酸鎂、硫酸鎂、錳、鉬、磷、鉀、磷酸鉀、碘化鉀、氯化
鉀、醋酸鉀、硒、硫、鈉、多庫酯鈉、氯化鈉、硒酸鈉、鉬酸鈉、鋅、氧化鋅、硫酸鋅及彼等之混合物。礦物質化合物之非限制性示例性衍生物包括任何礦物質化合物之鹽、鹼鹽、酯和螯合物。
礦物質可以鹽之形式(諸如磷酸鈣、甘油磷酸鈣、檸檬酸鈉、氯化鉀、磷酸鉀、磷酸鎂、硫酸亞鐵、硫酸鋅、硫酸銅、硫酸錳及亞硒酸鈉)被添加到成長乳品或其他兒童營養組成物中。可以依本技藝領域內所已知者添加其他維生素和礦物質。
於一實施例中,該兒童營養組成物可含有約10至約50%之任何指定國家對維生素A、C、E、鋅、鐵、碘、硒和膽鹼每次用量的最大膳食建議量,或約10至約50%之國家群組對維生素A、C、E、鋅、鐵、碘、硒和膽鹼每次用量的平均膳食建議量。於另一實施例中,該兒童營養組成物可供應約10至30%之任何指定國家對維生素B每次用量的最大膳食建議量,或約10至30%之國家群組對維生素B每次用量的平均膳食建議量。再於另一實施例中,該兒童營養產品中之維生素D、鈣、鎂、磷和鉀的水準可與乳品中發現之平均水準相對應。再於其他實施例中,該兒童營養組成物中之其他營養素的存在量可為約20%之任何指定國家對每次用量的最大膳食建議量,或約20%之國家群組對每次用量之平均膳食建議量。
本揭露內容之兒童營養組成物可選擇性地包
括一或多種以下調味劑,包括,但不限於調味之萃取物、揮發油、可可粉或巧克力調味劑、花生醬調味劑、餅乾屑、香草或任何市售之調味劑。有用之調味劑的實例包括,但不限於純茴香萃取物、仿香蕉萃取物、仿櫻桃萃取物、巧克力萃取物、純檸檬萃取物、純柳橙萃取物、純薄荷萃取物、蜂蜜、仿鳳梨萃取物、仿籣姆酒萃取物、仿草莓萃取物、或香草精;或揮發油,諸如香蜂花油(balm oil)、月桂油、佛手柑油、柏木油(cedarwood oil)、櫻花精油、肉桂油、丁香油或薄荷油;花生醬、巧克力調味劑、香草餅乾屑、奶油糖果、太妃糖及彼等之混合物。調味劑的量可根據所使用之調味劑而有很大的變化。調味劑之類型和量可依本技藝所已知者選擇。
本揭露內容之營養組成物可選擇性地包括一或多種可添加以穩定該最終產品之乳化劑。合適之乳化劑實例包括,但不限於卵磷脂(例如來自卵或大豆)、α-乳白蛋白和/或單-及二甘油酯,及彼等之混合物。熟習本技藝之人士可輕易明瞭其他乳化劑,而合適之乳化劑之選擇將部分取決於該配方和最終產品。
本揭露內容之營養組成物可選擇性地包括一或多種亦可添加以延長產品之貨架期的防腐劑。合適之防腐劑包括,但不限於山梨酸鉀、山梨酸鈉、苯甲酸鉀、苯甲酸鈉、乙二胺四醋酸二鈉鈣,及彼等之混合物。
本發明之營養組成物可選擇性地包括一或多種穩定劑。用於實行本揭露內容之營養組成物的合適穩定
劑包括,但不限於阿拉伯膠、甘地、刺梧桐樹膠、黃蓍膠、瓊脂、叉紅藻膠、古亞膠、結冷膠、刺槐豆膠、果膠、低甲氧基果膠、明膠、微晶型纖維素、CMC(羧甲基纖維素鈉)、甲基纖維素、羥丙基甲基纖維素、羥丙基纖維素、DATEM(單-和二甘油酯之二乙醯基酒石酸酯)、右旋糖苷、角叉菜膠、及彼等之混合物。
本揭露內容之營養組成物可提供最低限度、部分或全部之營養支持。該組成物可為營養補充品或代餐。該組成物可為,但不必須是,營養完整的。於一實施例中,本揭露內容之營養組成物為營養完整的且含有合適類型和量之脂質、碳水化合物、蛋白質、維生素和礦物質。脂質或脂肪之量通常可在約2至約7克/100千卡之間變化。蛋白質之量通常可在約1至約5克/100千卡之間變化。碳水化合物之量通常可在約8至約14克/100千卡之間變化。
於一些實施例中,本揭露內容之營養組成物為成長乳品。成長乳品為欲供1歲以上(通常是1-6歲)之兒童飲用的以強化乳品為底質之飲料。成長乳品之設計旨在作為多樣化膳食之補充,以提供額外保障使兒童達到持續每天攝入所有必須維生素和礦物質、大量營養素,加上額外之功能性膳食組分,諸如那些具有聲稱之促進健康之性能的非必須營養素。
根據本揭露內容之嬰兒配方或成長乳品或其他營養組成物之確切組成在不同市場之間可根據在地法規
和所欲族群之膳食攝入量資訊而有所變化。於一些實施例中,根據本揭露內容之營養組成物係由乳品蛋白來源(諸如全脂或脫脂奶),加上所添加之用來取得所需之感官特性的糖和甜味劑,以及添加之維生素和礦物質組成。該脂肪組成物通常係源自乳品原料。總蛋白質之目標為符合人類乳品、牛乳或較低的數值。總碳水化合物之目標通常為提供儘可能少之添加糖(諸如蔗糖或果糖)來取得可接受之味道。通常,添加之維生素A、鈣和維生素D之水準要符合區域牛乳之營養貢獻。或者,於一些實施例中,維生素和礦物質之添加水準為可提供每份量約20%之膳食營養素參考攝入量(DRI)或20%之日需值(DV)。此外,根據所欲族群之鑑定的營養需求、原料貢獻和地區法規,營養素值在不同市場之間可有所變化。
除非另有規定或明確暗示與所引用之背景相反,本揭露內容中之單數特性或限制的所有引用應包括對應之複數特性或限制,反之亦然。
除非另有規定或明確暗示與所引用之背景相反,本文所使用之方法或過程步驟的所有組合可以任何順序執行。
本揭露內容之方法和組成物(包括其組分)可包含此處所描述之實施例的要素和限制、以及任何額外或可選擇之成分,此處所描述或其他可用於營養組成物中之組分或限制,由彼等所組成或實質上由彼等所組成。
此處所使用之術語“約”應解釋為係指任何
範圍中所具體指定之兩個數字。對範圍之任何引用應被認為係提供對該範圍內之任何子集的支持。
提供之實例係用於說明本揭露內容之營養組成物的一些實施例,但不應被解釋為對本揭露內容之任何限制。熟習本技藝之人士從考量本專利說明書或實行此處所揭露營養之組成物或方法可清楚明白在本文之申請專利範圍內的其他實施例。本專利說明書,連同實例被認為僅用於示例,本揭露內容之範圍和精神係由接續在實例後之申請專利範圍所指定。
包含此處所描述之奶精組成物的兒童營養組成物之實例(諸如以強化乳品為底質之成長乳品)包含蛋白質來源、碳水化合物來源、包含此處所描述之奶精組成物的脂肪來源,及額外之成分,諸如果寡糖、菊糖、DHA、β-葡聚糖和各種維生素、礦物質及其他微量營養素。更特別地,根據本揭露內容之成長乳品包含表3中列出的成分:
一種包含營養奶精之示例性成長乳品具有表4中總結之營養組合形廓:
本專利說明書中所引用之所有文獻,包括,但不限於所有論文、出版物、專利案、專利申請案、演示、文本、報告、手稿、手冊、書籍、網路貼文、雜誌文章、期刊,等的全部內容在此以引用方式被納入本專利說明書中。本文中參考文獻的討論只是為了概述由其作者所下之斷言,並非承認任何引用構成先前技藝。本申請人有權質疑所引用之參考資科的準確性和相關性。
雖然本揭露內容之實施例已使用特定術語、裝置和方法描述,這類描述僅用於說明目的。所使用之文字是描述,而非限制之文字。可理解的是,本技藝之一般技術人士可在不背離本揭露內容之精神和範圍(這些列於接續之申請專利範圍內)的情況下作出各種改變和變化。此外,應理解的是,各種實施例之觀點可以全部或部分互換。例如,雖然已示例用於生產根據那些方法製造之市售無菌液體營養補充物的方法,仍可以考慮其他用途。因此,所附之申請專利範圍的精神和範圍不應只限於其中所包含之版本的說明。
Claims (17)
- 一種包含奶精組成物之兒童營養產品,其中該奶精組成物包含:含有至多約15重量%之飽和脂肪酸、約45至約75重量%之單不飽和脂肪酸、約15至約45重量%之多不飽和脂肪酸、及約0.1至約3重量%之反式脂肪酸的植物油摻和物;其中該植物油摻和物包含約30至約70重量%之芥菜油、約10至約45重量%之大豆油或葵花油及約10至約50重量%之高油酸油(high oleic oil)。
- 如申請專利範圍第1項之兒童營養產品,其中該植物油摻和物包含約45至約75重量%之油酸、約10至約40重量%之亞油酸、及約1至約15重量%之α-亞麻仁油酸。
- 如申請專利範圍第1項之兒童營養產品,其中該高油酸油係選自下列所組成之群組:高油酸葵花油、高油酸玉米油、高油酸大豆油、高油酸芥菜油、高油酸紅花油及彼等之混合物。
- 如申請專利範圍第1項之兒童營養產品,其中該高油酸油包含高油酸葵花油。
- 如申請專利範圍第1項之兒童營養產品,其中該奶精組成物為粉末狀奶精。
- 如申請專利範圍第5項之兒童營養產品,其中該粉末狀奶精包含經噴霧乾燥之基質。
- 如申請專利範圍第1項之兒童營養產品,其中該奶精組成物進一步包含選自下列所組成之群組的附加成分:載體、穩定劑、乳化劑、抗氧化劑、加工助劑及彼等之混合物。
- 如申請專利範圍第7項之兒童營養產品,其中該附加成分係選自下列所組成之群組:乳蛋白、改質澱粉、酪蛋白酸鉀或鈉、單或二甘油酯、抗壞血酸棕櫚酸酯、卵磷脂、混合之生育酚、麥芽糊精、乳糖、澱粉、乳清蛋白濃縮物、磷酸鹽、檸檬酸鹽及彼等之混合物。
- 如申請專利範圍第1項之兒童營養產品,其中該奶精組成物包含約40至約70重量%之脂肪。
- 如申請專利範圍第1項之兒童營養產品,其中該兒童營養產品為成長乳品。
- 如申請專利範圍第1項之兒童營養產品,其進一步包含:蛋白質來源,碳水化合物來源,及脂質來源,其中該脂質來源包含該奶精組成物。
- 如申請專利範圍第11項之兒童營養產品,其包含至多約50重量%之該奶精組成物。
- 如申請專利範圍第11項之兒童營養產品,其包含每100克之該兒童營養產品:約8至約20克之脂質來源,約50至約65克之碳水化合物來源,及約14至約25克之蛋白質來源。
- 如申請專利範圍第11項之兒童營養產品,其包含每100克之該兒童營養產品:約1至約7克之飽和脂肪約2.5至約10克之單不飽和脂肪約0.5至約10克之多不飽和脂肪及約0.1至1克之反式脂肪。
- 如申請專利範圍第11項之兒童營養產品,其包含每100克之該兒童營養產品:約0.5至約5克之棕櫚酸,約0.5至約2克之硬脂酸,約1至約10克之油酸,約0.5至約8克之亞油酸,約0.1至約2克之α-亞麻仁油酸,及約25至約200毫克之二十二碳六烯酸。
- 如申請專利範圍第11項之兒童營養產品,其中約4至約8%之該組成物的總能量來自亞油酸、約1至約2%之該組成物的總能量來自α-亞麻仁油酸、約10%或更少之該組成物的總能量來自多不飽和脂肪酸、約10%或更少之總能量來自飽和脂肪酸,且約1%或更少之該能量來自反式脂肪酸。
- 如申請專利範圍第11項之兒童營養產品,其為成長乳品。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/565,339 | 2012-08-02 | ||
US13/565,339 US20140037813A1 (en) | 2012-08-02 | 2012-08-02 | Nutritional creamer composition |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201420017A TW201420017A (zh) | 2014-06-01 |
TWI635803B true TWI635803B (zh) | 2018-09-21 |
Family
ID=48875743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW102124518A TWI635803B (zh) | 2012-08-02 | 2013-07-09 | 營養奶精組成物 |
Country Status (19)
Country | Link |
---|---|
US (1) | US20140037813A1 (zh) |
EP (1) | EP2879508B1 (zh) |
CN (2) | CN104486952A (zh) |
AR (1) | AR094529A1 (zh) |
AU (1) | AU2013297010B2 (zh) |
BR (1) | BR112015001794A2 (zh) |
CA (1) | CA2879393C (zh) |
CO (1) | CO7200285A2 (zh) |
ES (1) | ES2755744T3 (zh) |
HK (1) | HK1208307A1 (zh) |
IN (1) | IN2015DN00181A (zh) |
MX (1) | MX362808B (zh) |
MY (1) | MY169756A (zh) |
PE (1) | PE20150868A1 (zh) |
PH (1) | PH12015500228B1 (zh) |
RU (1) | RU2015106610A (zh) |
SG (2) | SG11201408771UA (zh) |
TW (1) | TWI635803B (zh) |
WO (1) | WO2014022051A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3579700A1 (en) * | 2017-02-08 | 2019-12-18 | Société des Produits Nestlé S.A. | Creamers compositions |
US20200329726A1 (en) * | 2017-12-22 | 2020-10-22 | Societe Des Produits Nestle S.A | Creamer composition |
CN109169958A (zh) * | 2018-09-30 | 2019-01-11 | 上海海融食品科技股份有限公司 | 植脂奶油组合物及其制备方法和果味冰淇淋 |
CN113115843B (zh) * | 2019-12-30 | 2023-12-19 | 丰益(上海)生物技术研发中心有限公司 | 含藻油的结构化乳液 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1108893A (zh) * | 1993-08-20 | 1995-09-27 | 雀巢制品公司 | 预期用作食物或用于食品的类脂组合物 |
CN1973646A (zh) * | 2006-12-20 | 2007-06-06 | 秦皇岛金海粮油工业有限公司 | 一种婴幼儿配方奶粉专用油 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
ES2033193B1 (es) | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
BR9205526A (pt) | 1991-01-24 | 1994-04-19 | Martek Corp Sociedade Norte Am | Misturas de oleos microbianos e usos dos mesmos |
US5308832A (en) * | 1992-07-27 | 1994-05-03 | Abbott Laboratories | Nutritional product for persons having a neurological injury |
CA2150741A1 (en) * | 1994-06-17 | 1995-12-18 | Susan Trimbo | Pediatric lipid emulsion |
NL1001372C2 (en) * | 1994-10-06 | 1996-09-12 | Friesland Brands Bv | Milk-based food for pregnant and lactating women - is supplemented with docosa:hexaenoic acid, eicosa:pentaenoic acid and nutrient fibres, reduce systemic complications during pregnancy |
US6589586B2 (en) * | 1996-08-21 | 2003-07-08 | Nestec S.A. | Cold beverage creamer |
US6374657B1 (en) | 2000-10-30 | 2002-04-23 | Crown Cork & Seal Technologies Corporation | Method of making bump-up can bottom |
GB0027761D0 (en) * | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
US20030170374A1 (en) * | 2002-03-05 | 2003-09-11 | Robert Bahoshy | Condiments including nutritional supplements |
PT1638416E (pt) * | 2003-06-23 | 2013-07-08 | Nestec Sa | Utilização de uma fórmula nutricional para função de barreira intestinal óptima |
IL158554A0 (en) * | 2003-10-22 | 2004-05-12 | Enzymotec Ltd | Mimetic lipids as dietary supplements |
US20050215640A1 (en) * | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
US20060115553A1 (en) * | 2004-12-01 | 2006-06-01 | Slim-Fast Foods Company, Division Of Conopco, Inc. | Nutrition bar or other food product and process of making |
WO2007021899A1 (en) * | 2005-08-10 | 2007-02-22 | Bunge Oils, Inc. | Edible oils and methods of making edible oils |
MY157300A (en) * | 2007-10-19 | 2016-05-31 | Fontera Co Operative Group Ltd | Methods of maintaining or increasing growth or cognitive development |
US20110177224A1 (en) * | 2008-03-03 | 2011-07-21 | Daniel Perlman | Stabilization of omega-3 fatty acids in oil-water emulsions |
EP2432328A1 (en) * | 2009-05-22 | 2012-03-28 | Stepan Specialty Products, LLC | Fat blends and uses thereof |
WO2011042356A1 (en) * | 2009-10-05 | 2011-04-14 | Nestec S.A. | Method for preparing a beverage from a beverage powder and apparatus for implemeting the method |
MX2012008778A (es) * | 2010-01-29 | 2012-09-07 | Abbott Lab | Polvos nutricionales que comprenden hmb secado por aspersion. |
RU2013150824A (ru) * | 2011-04-15 | 2015-05-20 | Нестек С.А. | Композиция стабильного забеливателя |
-
2012
- 2012-08-02 US US13/565,339 patent/US20140037813A1/en not_active Abandoned
-
2013
- 2013-07-02 BR BR112015001794A patent/BR112015001794A2/pt not_active IP Right Cessation
- 2013-07-02 WO PCT/US2013/049057 patent/WO2014022051A1/en active Application Filing
- 2013-07-02 AU AU2013297010A patent/AU2013297010B2/en not_active Ceased
- 2013-07-02 CN CN201380039603.6A patent/CN104486952A/zh active Pending
- 2013-07-02 MX MX2015000631A patent/MX362808B/es active IP Right Grant
- 2013-07-02 CA CA2879393A patent/CA2879393C/en not_active Expired - Fee Related
- 2013-07-02 SG SG11201408771UA patent/SG11201408771UA/en unknown
- 2013-07-02 SG SG11201408771L patent/SG11201408771LA/en unknown
- 2013-07-02 MY MYPI2014704071A patent/MY169756A/en unknown
- 2013-07-02 PE PE2015000097A patent/PE20150868A1/es not_active Application Discontinuation
- 2013-07-02 ES ES13742071T patent/ES2755744T3/es active Active
- 2013-07-02 RU RU2015106610A patent/RU2015106610A/ru not_active Application Discontinuation
- 2013-07-02 CN CN201910170903.7A patent/CN110074416A/zh active Pending
- 2013-07-02 EP EP13742071.7A patent/EP2879508B1/en not_active Revoked
- 2013-07-02 IN IN181DEN2015 patent/IN2015DN00181A/en unknown
- 2013-07-09 TW TW102124518A patent/TWI635803B/zh not_active IP Right Cessation
- 2013-07-30 AR ARP130102694A patent/AR094529A1/es unknown
-
2015
- 2015-02-02 PH PH12015500228A patent/PH12015500228B1/en unknown
- 2015-02-18 CO CO15035123A patent/CO7200285A2/es unknown
- 2015-09-21 HK HK15109233.1A patent/HK1208307A1/zh unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1108893A (zh) * | 1993-08-20 | 1995-09-27 | 雀巢制品公司 | 预期用作食物或用于食品的类脂组合物 |
CN1973646A (zh) * | 2006-12-20 | 2007-06-06 | 秦皇岛金海粮油工业有限公司 | 一种婴幼儿配方奶粉专用油 |
Also Published As
Publication number | Publication date |
---|---|
TW201420017A (zh) | 2014-06-01 |
BR112015001794A2 (pt) | 2017-07-04 |
MX362808B (es) | 2019-02-14 |
MY169756A (en) | 2019-05-15 |
CA2879393A1 (en) | 2014-02-06 |
MX2015000631A (es) | 2015-04-14 |
AU2013297010B2 (en) | 2016-09-15 |
SG11201408771UA (en) | 2015-01-29 |
AR094529A1 (es) | 2015-08-12 |
CN104486952A (zh) | 2015-04-01 |
ES2755744T3 (es) | 2020-04-23 |
CN110074416A (zh) | 2019-08-02 |
CO7200285A2 (es) | 2015-02-27 |
US20140037813A1 (en) | 2014-02-06 |
CA2879393C (en) | 2020-04-21 |
AU2013297010A1 (en) | 2015-01-29 |
IN2015DN00181A (zh) | 2015-06-12 |
PH12015500228A1 (en) | 2015-04-06 |
SG11201408771LA (en) | 2015-01-29 |
EP2879508B1 (en) | 2019-08-21 |
EP2879508A1 (en) | 2015-06-10 |
PH12015500228B1 (en) | 2015-04-06 |
HK1208307A1 (zh) | 2016-03-04 |
PE20150868A1 (es) | 2015-06-21 |
RU2015106610A (ru) | 2016-09-20 |
WO2014022051A1 (en) | 2014-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2014219364B2 (en) | Amino acid and protein hydrolysate based formulas with a stable emulsion system | |
US9661874B2 (en) | Nutritional compositions containing structured fat globules and uses thereof | |
TW201513797A (zh) | 含有富集脂質之餾分的營養組成物及其用途 | |
US20160015068A1 (en) | Nutritional formulas containing oil blends and uses thereof | |
US9980506B2 (en) | Nutritional compositions containing structured fat globules and uses thereof | |
US10455854B2 (en) | Nutritional compositions containing structured fat globules and uses thereof | |
AU2013372899A1 (en) | Nutritional compositions containing magnesium threonate and uses thereof | |
TW201208583A (en) | Nutritional compositions | |
US20150064222A1 (en) | Nutritional compositions for enhancing immune function | |
EP3373749A1 (en) | Nutritional compositions containing butyrate and uses thereof | |
TWI635803B (zh) | 營養奶精組成物 | |
AU2013360215B2 (en) | Nutritional composition for promoting satiety | |
US20140170265A1 (en) | Infant formula cubes | |
Gonzalez et al. | THAT ARE NOT OULUULUTUTE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |